Practical guidelines for the use of converting enzyme inhibitors in congestive heart failure
- 30 April 1987
- journal article
- review article
- Published by Elsevier in International Journal of Cardiology
- Vol. 15 (1) , 1-5
- https://doi.org/10.1016/0167-5273(87)90286-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Comparison of Captopril and Enalapril in Patients with Severe Chronic Heart FailureNew England Journal of Medicine, 1986
- Treatment of chronic heart failure: a review of recent drug trials.BMJ, 1985
- Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failureJournal of the American College of Cardiology, 1985
- Captopril in heart failure. A double blind controlled trial.Heart, 1984
- Acute and chronic hemodynamic effects of enalapril (MK-421) in congestive heart failureInternational Journal of Cardiology, 1984
- Renal Response to Captopril in Severe Heart Failure: Role of Furosemide in Natriuresis and Reversal of HyponatremiaAnnals of Internal Medicine, 1984
- Cerebral blood flow in patients with congestive heart failure treated with captoprilThe American Journal of Medicine, 1984
- Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failureJournal of the American College of Cardiology, 1984
- Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captoprilThe American Journal of Medicine, 1982
- Role of angiotensin II in the physiologic regulation of glomerular filtrationThe American Journal of Cardiology, 1982